A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 29, 2025

Primary Completion Date

July 16, 2025

Study Completion Date

July 28, 2025

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

NNC0471-0119 H

NNC0471-0119 H will be administered subcutaneously.

DRUG

Insulin aspart

Insulin aspart will be administered subcutaneously.

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss